COMPOSITIONS AND METHODS FOR TCR REPROGRAMMING USING FUSION PROTEINS

摘要

Disclosed herein are dosage and administration methods for treatment of a mesothelin-expressing cancer in a human comprising administration of, e.g., a plurality of anti-mesothelin T cell receptor fusion protein - expressing T cells.